1. Home
  2. CMDB vs IPSC Comparison

CMDB vs IPSC Comparison

Compare CMDB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CMDB

Costamare Bulkers Holdings Limited

HOLD

Current Price

$17.41

Market Cap

427.0M

Sector

N/A

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.36

Market Cap

425.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMDB
IPSC
Founded
2023
2019
Country
Monaco
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
427.0M
425.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CMDB
IPSC
Price
$17.41
$2.36
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
40.2K
1.4M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$8.46
$0.44
52 Week High
$19.93
$2.97

Technical Indicators

Market Signals
Indicator
CMDB
IPSC
Relative Strength Index (RSI) 54.51 51.54
Support Level $14.90 $1.87
Resistance Level $17.56 $2.42
Average True Range (ATR) 0.73 0.18
MACD 0.11 0.03
Stochastic Oscillator 74.49 53.28

Price Performance

Historical Comparison
CMDB
IPSC

About CMDB Costamare Bulkers Holdings Limited

Costamare Bulkers Holdings Ltd is an international owner and operator of dry bulk vessels providing transportation of dry bulk commodities globally for a broad range of customers. Its vessels transport a broad range of bulks, such as iron ore, coal and grains and minor bulks, such as bauxite, phosphate fertilizers and steel products, across shipping routes globally. The company's vessel fleet includes Current Dry Bulk Fleet, Chartered-In Vessels Fleet, and Chartered-In Newbuilding Vessels. It operates under one reportable segment, that of operating dry bulk vessels.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: